$3.96
-0.22-5.26%
At close: -
$3.96
0.000.00%
After Hours: Jan 31, 4:01 PM EDT
Comments
Loading...
Fulcrum Therapeutics (NASDAQ:FULC) Stock, Earnings Estimates, EPS, And Revenue
Fulcrum Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 25
EPS Estimate
$-0.290
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$80.87M
Analyze the earnings history of Fulcrum Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Fulcrum Therapeutics (FULC) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-13 | $-0.32 | $-0.41 | 21.9 % |
| Q2 | 2024-07-31 | $0.87 | $-0.01 | 8800.0 % |
| Q1 | 2024-05-13 | $-0.43 | $-0.44 | 2.27 % |
| Q4 | 2024-02-27 | $-0.40 | $-0.43 | 6.98 % |
Fulcrum Therapeutics (FULC) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | 2024-07-31 | $80.00M | $36.54M | 118.9 % |
| Q1 | 2024-05-13 | $0 | $360.00K | -100.0 % |
| Q4 | 2024-02-27 | $871.00K | $460.00K | 89.3 % |
| Q3 | 2023-11-07 | $759.00K | $1.05M | -27.7 % |
FAQ
When is Fulcrum Therapeutics (NASDAQ:FULC) reporting earnings?
Fulcrum Therapeutics (FULC) is scheduled to report earnings on February 25, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
What were the latest earnings per share (EPS) for Fulcrum Therapeutics (NASDAQ:FULC)?
The Actual EPS was $-0.32, which beat the estimate of $-0.41.
What were Fulcrum Therapeutics’s (NASDAQ:FULC) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.